An integrated computational approach to rationalize the activity of non-zinc-binding MMP-2 inhibitors.
Matrix metalloproteinases are a family of Zn-proteases involved in tissue remodeling and in many pathological conditions. Among them MMP-2 is one of the most relevant target in anticancer therapy. Commonly, MMP inhibitors contain a functional group able to bind the zinc ion and responsible for undes...
Main Authors: | Antonella Di Pizio, Mariangela Agamennone, Massimiliano Aschi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23144829/pdf/?tool=EBI |
Similar Items
-
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies
by: Alessandra Ammazzalorso, et al.
Published: (2016-10-01) -
Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies
by: Thomas Fischer, et al.
Published: (2016-03-01) -
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy
by: Antonio Laghezza, et al.
Published: (2020-06-01) -
BIOCHEMICAL CHARACTERIZATION AND ZINC BINDING GROUP (ZBGS) INHIBITION STUDIES ON THE CATALYTIC DOMAINS OF MMP7 (CDMMP7) AND MMP16 (CDMMP16)
by: Meng, Fan
Published: (2016) -
Evaluation of zinc binding groups (ZBGs) as inhibitor building blocks using carbonic anhydrase and the catalytic domain of matrix metalloproteinase 12 (cdMMP-12)
by: Craig, Whitney Richert
Published: (2017)